Placeholder

Fostering interactions among industry, investors, government, and academia

2022 BioMarin Golden Ticket

Add to Calendar 08/22/2022 11:59 PM 08/22/2022 11:59 PM America/New_York 2022 BioMarin Golden Ticket Applications Open for BioMarin-Sponsored LabCentral Golden Ticket, 2022!


As a Gold Sponsor of LabCentral, BioMarin Pharmaceutical Inc. is excited to expand their interactions with the Boston biotech community and support promising start-ups as they work to advance innovations towards new therapeutic options for patients.
LabCentral

Applications Open for BioMarin-Sponsored LabCentral Golden Ticket, 2022!


As a Gold Sponsor of LabCentral, BioMarin Pharmaceutical Inc. is excited to expand their interactions with the Boston biotech community and support promising start-ups as they work to advance innovations towards new therapeutic options for patients.
 
The Golden Ticket provides the winning start-up with a $50,000 credit towards space at LabCentral 700, including the benefits of LabCentral’s shared infrastructure and services, to be used within 13 months of issue.

Focus Area
BioMarin is looking for start-ups developing innovative therapeutic approaches and enabling technologies that can correct molecular pathways that are altered in genetic diseases. Our standard boundary conditions are:

  • Genetic disease, with prevalence at least 1:50,000
  • Treatment addressing the underlying molecular pathology
  • Significant unmet clinical need with discernable clinical endpoints
  • Transformative impact - where treatment is expected to stop progression or provide reversal
  • Excluded therapeutic areas: oncology, infectious disease 

Technology Scope
We are interested in a broad range of modalities including:

  • Small Molecule and Biologic therapeutic approaches
  • Gene Therapy and Gene Editing
  • Oligonucleotide and mRNA directed therapies
  • Cell based therapies

Eligibility

  • Your start-up is working on innovation within BioMarin's focus area
  • Your start-up has raised less than $7.5M in equity financing
  • Your start-up does not have trailing 12-month revenues in excess of $3M
  • Your start-up will be able to utilize the value of the Golden Ticket towards space at LabCentral within 13 months of issue

Timelines

  • Open call applications and application agreements accepted through 11:59pm PST 08/22/22
  • Finalists informed by 09/07/22
  • Finalists will be invited to present to BioMarin during a virtual pitch event on 09/27/22
  • Golden Ticket winner will be announced soon after the pitch event

APPLY HERE

Our Privacy Policy can be reviewed here: www.biomarin-global-privacy.com
Competition Terms and Conditions can be reviewed here: https://bit.ly/3RkTTW3 (PDF)
Application Agreement can be found here: https://bit.ly/3yKoD99